Scinai Immunotherapeutics, which focuses on developing inflammation and immunology biological products and providing CDMO services through its Scinai Bioservices business…

Craniopharyngioma, a benign yet highly invasive tumor occurring along the hypothalamus-pituitary axis, presents a unique clinical challenge. Although nonmalignant, its…

Akamis Bio, a clinical-stage oncology company, has raised $60 million in Series A funding that will drive continued development of…

Researchers at NYU College of Dentistry and NYU Grossman School of Medicine reported the findings of a study in mice…

The process by which fungi synthesize some of their most potent compounds has remained unclear for many years. This is…

Broadcast Date:  Wednesday, January 29, 2025Time:  8:00 am PT, 11:00 am ET, 17:00 CET The field of cell and gene…

Messenger RNA-based vaccine production has become a major industry focus, thanks to the success of jabs developed during the pandemic.…

Recently, Charles River Laboratories—a provider of products and services for drug research and development—presented a webinar about starting material for…

As steadily increasing numbers of mRNA vaccines and therapeutics advance through clinical trials and commercialization, the biopharmaceutical industry is pressed…

A biopharma company specializing in difficult-to-produce biologics has developed a deep learning model to rapidly predict protein expression using their…